Overview
Ewopharma Ag, founded in 1959, gives partner companies access to pharmaceutical markets in Central and Eastern Europe and Switzerland. It supports pharmaceutical companies with tailored medical marketing and the introduction of pharmaceutical and health products into target markets.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 46 days early. All were audited by a statutory auditor.
- 202522/05/2026
- 202404/06/2025
- 202304/06/2024
- 202223/06/2023
- 202106/07/2022
- 202030/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Medical marketing
- Medicines
- Over-the-counter products
- Access to pharmaceutical markets
Website technology
- Analytics and marketing
- Google Analytics
Trademarks
Ewopharma Ag currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2008.
| Mark | Protected until | |
|---|---|---|
| Revalid®. Liczy się każdy włos.(word) | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by the only member of the management board. If the management board is multi-member, the actions of two members of the management board jointly or of one member of the management board jointly with a commercial proxy are required to submit declarations and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewopharma Ag | 1,468 | $198,271.20 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-11-30.
68 1090 1883 0000 0001 5119 5864- 74 1090 1883 0000 0001 5119 5756
19 1160 2202 0000 0005 4241 5732
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 3, 2011 | Return of additional payments |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $21,449$21,449 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $16,317$16,317 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $17,742$17,742 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medical Plannerssp. z o.o. | $2,632,110.13 | medicalplanners.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-01-08 | Address change (Świętokrzyska 36/16, 00-116, Warszawa → Ul. Leszno 14, 01-192, Warszawa) | |
| 2006-01-25 | Share capital reduction (5,606,000.00 PLN → 734,000.00 PLN) | |
| 2004-11-03 | Share capital increase (734,000.00 PLN → 5,606,000.00 PLN) | |
| 2002-02-07 | Entered in the register |
FAQ
Last updated: 2026-10-07